Results 51 to 60 of about 39,706 (298)

カベオリン異常症における特徴的な骨格筋MRI画像所見に関する検討 [PDF]

open access: yes, 2019
博士(医学) 甲第702号(主論文の要旨、要約、審査結果の要旨、本文),著者名:Kumiko IHIGURO・Takahiro NAKAYAMA・Masaru YOSHIOKA・Terumi MURAKAMI・Sachiko KAJINO・Minobu SHICHIJI・Takatoshi SATO・Naomi HINO-FUKUYO・Satoshi KURU・Makiko OSAWA・Satoru NAGATA・Mariko OKUBO・Nobuyuki MURAKAMI・Yukiko K ...
石黒 久美子
core   +2 more sources

Lipodystrophy in HIV/AIDS patients with different levels of physical activity while on antiretroviral therapy

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2011
INTRODUCTION: Lipodystrophy is related to the use of highly active antiretroviral therapy (HAART) and can cause aesthetic stigma and increase the risk of developing cardiovascular diseases.
Aline Francielle Mota Segatto   +6 more
doaj   +1 more source

Leptin decreases de novo lipogenesis in patients with lipodystrophy.

open access: yesJCI Insight, 2020
De novo lipogenesis (DNL) plays a role in the development of hepatic steatosis. In humans with lipodystrophy, reduced adipose tissue causes lower plasma leptin, insulin resistance, dyslipidemia and ectopic triglyceride (TG) accumulation.
Annah P. Baykal   +14 more
semanticscholar   +1 more source

Implementing a tenofovir-based first-line regimen in rural Lesotho: clinical outcomes and toxicities after two years. [PDF]

open access: yes, 2011
The latest World Health Organization guidelines recommend replacing stavudine with tenofovir or zidovudine in first-line antiretroviral therapy in resource-limited settings.
Birkus   +12 more
core   +2 more sources

Lipodystrophy among HIV-Infected Patients Attending Care and Treatment Clinics in Dar es Salaam

open access: yesAIDS Research and Treatment, 2017
Background. HIV infection and long-term HAART use are associated with metabolic and morphological changes. We assessed prevalence, types, and risk factors associated with lipodystrophy among HIV-infected adults attending CTC in Dar es Salaam, Tanzania ...
Marina Njelekela   +5 more
doaj   +1 more source

Cytokine profile and clinical metabolic alterations in HIV-1 infected individuals with and without lipodistrophy

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2007
The extensive use of Highly Active Antiretroviral Therapy (HAART) has transformed HIV infection into a chronic condition. Thus, metabolic alterations including lipodystrophy and dyslipidemia have been associated with the use of such medications.
L. C. R. Pontes-Cardoso   +3 more
doaj   +1 more source

Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin

open access: yesDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 2020
Background Lipodystrophy has been reported as a common complication in insulin-treated patients, which could lead to unexplained hypoglycemia and suboptimal glycemic control.
Y. Thewjitcharoen   +10 more
semanticscholar   +1 more source

Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho [PDF]

open access: yes, 2011
Article approval pendingLatest World Health Organization guidelines recommend shifting away from Stavudine (d4T)-based regimens due to severe side effects.
Bygrave, Helen   +11 more
core   +2 more sources

Inherited and acquired lipodystrophies: molecular-genetic and autoimmune mechanisms

open access: yesОжирение и метаболизм, 2018
Lipodystrophy syndromes form a heterogenous group of inherited or acquired rare disorders, characterized by total (generalized lipodystrophy) or partial fat loss (partial lipodystrophy), usually accompanied by different metabolic disorders.
Ekaterina L. Sorkina   +1 more
doaj   +1 more source

Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease

open access: yesFrontiers in Endocrinology, 2020
Berardinelli-Seip congenital lipoatrophy (BSCL) is characterized by near total fat atrophy, associated with the progressive development of metabolic complications. BSCL type 1 (BSCL1) is caused by mutations in AGPAT2, encoding 1-acylglycerol-3phosphate-O-
Giovanni Ceccarini   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy